Aristada sales projection: $444M peak in 2031 (Jefferies) - Mar 29, 2021 - A subscription to REFINITIV is required to access document 91514310 | Page no: 02 | REPORT TITLE: "An evolving oncology program with ALKS 4230; Assuming coverage at hold" | AUTHOR: Biren Amin, et al | DATE: 03/01/21
Sales projection • Schizophrenia
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact OnDemand@refinitiv.com.
|